Skip to main content

Closed

RCKT: Rocket Pharmaceuticals, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

20thpctl

Volume

0.52×avg

Market Cap

339.59MUSD

P/E Ratio

-1.7TTM

Div Yield

-ann

Rocket Pharmaceuticals, Inc.

RCKTNASDAQ Global Market·USD·Closed

Rocket Pharmaceuticals, Inc.

RCKTNASDAQ·USD·Closed

$3.11

−3.12%

$3.11

−$0.10 (3.12%)

52W Range

20thpctl

Volume

0.52×avg

Mkt Cap

339.59MUSD

P/E

-1.7TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings